The drugmaker said clinical-trial data suggested the medicine, emugrobart, wouldn’t hit internal targets.

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

Creating new drugs to treat the panoply of diseases afflicting humanity is an expensive, lengthy and complex process. Fortunes are spent each year attempting to treat our most pernicious and ...

Twelve candidate indicators, based on studies in mice, could make developing anti-aging interventions faster-while offering ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...

Artificial intelligence (AI) can help identify molecules that could serve as new drugs for mental health disorders. AI can be used to predict the three-dimensional structures of important receptors ...

Progress in computing has long been described by Moore’s law, a rule of thumb which says that the cost of processing power falls by half roughly every two years. The pharmaceutical industry follows an ...